C (Pre-2000)

CANCER – BREAST
CANCER – GASTRIC
CANCER – GLIOMA / BRAIN CANCERS
CANCER – LEUKEMIA
CANCER – LUNG
CANCER – LYMPHOMA
CANCER – MELANOMA
CANCER – NEUROBLASTOMA
CANCER – ORAL
CANCER – PROSTATE
CANCER – RISK CANNABIS VS TOBACCO
CANCER – TESTICULAR
CANCER – VARIOUS / UNNAMED
CANNABINOIDS IN OTHER PLANTS
CBC / CANNABICHROMENE (Phytocannabinoid, Unknown Receptor)
CBD / CANNABIDIOL (Phytocannabinoid, Antagonist of CB1, CB2, GPR–55 & 18)
CBDA / CANNABIDIOLIC ACID (Phytocannabinoid, precursor to Cannabidiol)
CBG / CANNABIGEROL (Phytocannabinoid, CB2 Agonist)
CBR – CB1 CANNABINOID RECEPTOR (Activated by THC, Anandamide, Synthetics)
CBR – CB2 CANNABINOID RECEPTOR (No “High”, Activated by THC, Anandamide, 2 –AG, Synthetics)
CBR – CBe (Endothelial Cannabinoid Receptor)
CBR – GPR55 / CB3 CANNABINOID RECEPTOR (Activated by l-α-lysophosphatidylinositol [LPI] and To a Lesser Extent Possibly by THC, CBD,O-1602, PEA, 2-AG, Anandamide, Virodhamine)
CEREBRAL PALSY
CHEMICAL COMPOSITION
CHEMOTHERAPY
CHILDREN / YOUNG ADULTS
CHOCOLATE (Contains Small Amount of Anandamide and Compounds That Block its Breakdown)
CHOLERA
CHOLESTEROL
CHRONIC FATIGUE SYNDROME / MYALGIC ENCEPHALOMYELITIS
COLITIS (See Also BOWEL DISORDERS)
CP 47,497 (Synthetic, CB1 & CB2 Agonist)
CP 50,556-1 / LEVONANTRADOL (Synthetic, CB1 & CB2 Agonist)
CP 55,940 (Synthetic , CB1, CB2 & GPR-55 Agonist)
CROHN’S DISEASE (See Also BOWEL DISORDERS)
CYSTIC FIBROSIS


CANCER – BREAST
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation (full-1998) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC20983/


CANCER – GASTRIC
Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol) (full-1997) http://www.jpsmjournal.com/article/S0885-3924%2897%2900229-7/pdf


CANCER – GLIOMA / BRAIN CANCERS
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells (full-1992) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC525583/
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells (abst–1993) http://www.ncbi.nlm.nih.gov/pubmed/8371711
Δ9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells (full–1998) http://www.sciencedirect.com/science/article/pii/S0014579398010850
top


CANCER – LEUKEMIA
Effects of cannabinoids on L1210 murine leukemia. 1. Inhibition of DNA synthesis (abst-1977) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=897352&dopt=abstractplus
Cannabinoids induce incomplete maturation of cultured human leukemia cells (full-1987) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC298868/?tool=pmcentrez&page=1
Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient (full-1988) http://journal.publications.chestnet.org/data/Journals/CHEST/21581/432.pdf


CANCER – LUNG
A pilot study of orally administered Δ1-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus (full-1974) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1402430/?tool=pmcentrez&page=1
Anticancer activity of cannabinoids (full-1975) http://drugpolicycentral.com/bot/pg/cancer/THC_cancer_sep_1975.htm
Antineoplastic activity of cannabinoids (full-1975) http://www.ukcia.org/research/AntineoplasticActivityOfCannabinoids/default.html
In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas (abst-1977) http://www.ncbi.nlm.nih.gov/pubmed/616322
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy (full-1983) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011510/?tool=pmcentrez&page=1
No increase in carcinogen-DNA adducts in the lungs of monkeys exposed chronically to marijuana smoke (abst–1992) http://www.ncbi.nlm.nih.gov/pubmed/1488780
Marijuana Less Harmful to Lungs than Cigarettes (news-1994) http://www.ukcia.org/research/lungs.php
So, you thought it was the tar that caused cancer… (news–1999) http://www.ukcia.org/research/cancer2.php


CANCER – LYMPHOMA
UCSF Researchers Report New Risk Factors For Non-Hodgkin’s Lymphoma (news-1999) http://www.sciencedaily.com/releases/1999/08/990817065339.htm


CANCER – MELANOMA
Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol) (full-1997) http://www.jpsmjournal.com/article/S0885-3924%2897%2900229-7/pdf


CANCER – NEUROBLASTOMA
Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds (abst–1984) http://www.ncbi.nlm.nih.gov/pubmed/6090851
Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes (abst–1985) http://www.ncbi.nlm.nih.gov/pubmed/2984538
top
Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells (abst–1987) http://www.ncbi.nlm.nih.gov/pubmed/2821958
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells (full-1992) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC525583/
Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism (full-1992) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1907498/?tool=pmcentrez&page=1
Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by delta 9-tetrahydrocannabinol (THC) (abst–1995) http://www.ncbi.nlm.nih.gov/pubmed/7702643
Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells (abst–1996) http://www.ncbi.nlm.nih.gov/pubmed/8858137
Tau protein after delta-9-tetrahydrocannabinol in a human neuroblastoma cell line (abst–1996) http://www.ncbi.nlm.nih.gov/pubmed/8981058


CANCER – ORAL
Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells (abst-1998) http://www.ncbi.nlm.nih.gov/pubmed/9875457


CANCER – PROSTATE
Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism (full-1999) http://www.sciencedirect.com/science/article/pii/S001457939901073X


CANCER – RISK CANNABIS VS TOBACCO
So, you thought it was the tar that caused cancer… (news-undated) http://www.ukcia.org/research/cancer2.php
Marijuana Less Harmful to Lungs than Cigarettes (news-1994) http://www.ukcia.org/research/lungs.php
Premiere British Medical Journal Pronounces Marijuana Safer Than Alcohol, Tobacco (news-1998) http://cannabislink.ca/medical/safer.html


CANCER – TESTICULAR
Chemotherapy for Testicular Cancer (anecdotal-undated) http://www.rxmarihuana.com/shared_comments/testicularchemo.htm
Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy (abst-1986) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=127


CANCER – VARIOUS / UNNAMED
Unpublished Federal Study Found THC-Treated Rats Lived Longer, Had Less Cancer (news-undated) http://www.drugsense.org/mcwilliams/www.marijuanamagazine.com/toc/rats.htm
Analgesic effect of delta-9-tetrahydrocannabinol (abst-1975) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=16
The analgesic properties of delta-9-tetrahydrocannabinol and codeine (abst-1975) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=17
top
Delta-9-Tetrahydrocannibinol as an Antiemetic in Cancer Patients Receiving High-Dose Methotrexate (full-1979) http://www.ukcia.org/research/AntiemeticForMethotrexate.php
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo (abst-1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=5
Delta-9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy; a double-blind cross-over trial against placebo (abst-1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=27
Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9–tetrahydrocannabinol (abst-1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=107
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy (abst-1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=126
The antiemetic activity of tetrahydrocanabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy (abst-1980) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=24
A ‘Tiger Of A Woman Takes On Conservative Georgia And Wins A Battle For Cancer
Victims (news–1980) http://www.gacareproject.com/flash-back-how-georgia-legalized-medical-marijuana/
A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting (abst-1982) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=156
Evaluation of the Use of Both Marijuana and THC in Cancer Patients for the Relief of Nausea and Vomiting Associated With Cancer Chemotherapy After Failure of Conventional Anti-Emetic Therapy: Efficacy and Toxicity (full–1983) http://www.gacareproject.com/wp-content/uploads/2014/02/Binder1.pdf
Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis (abst-1986) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=129
Efficacy of tetrahydrocannabinol in patients refractory to standard anti-emetic therapy (abst-1988) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=31
Dronabinol enhancement of appetite in cancer patients (abst-1990) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=149
Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy induced nausea and vomiting (abst-1991) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=28
A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer associated anorexia (abst-1994) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=52
NTP Technical Report on the Toxicology and Carcinogenesis Studies of 1-Trans-Delta9-Tetrahyrdocannabinol (CAS No. 1972-08-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies) (full-1996) http://www.druglibrary.org/Schaffer/hemp/Trans-Delta%20Report.pdf
Toxicity and Carcinogenicity of {Delta}9-Tetrahydrocannabinol in Fischer Rats and B6C3F1 Mice (full-1996) http://toxsci.oxfordjournals.org/content/30/1/109.full.pdf+html
Marijuana Use and Cancer Incidence (California, United States). Cancer Causes and Control (abst–1997) http://www.ncbi.nlm.nih.gov/pubmed/9328194
top
Study: THC Not Cancer-Causing (news-1997) http://www.ukcia.org/research/cancer.php
Study may undercut marijuana opponents – Report says THC did not cause cancer (news–1997) http://www.marijuanalibrary.org/Globe_mj_cancer_013097.html


CANNABINOIDS IN OTHER PLANTS
Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10080239


CBC / CANNABICHROMENE
Phytocannabinoids (news–undated) http://www.news-medical.net/health/Phytocannabinoids.aspx
Constituents of Cannabis sativa L. VIII: Possible biological application of a new method to separate cannabidiol and cannabichromene (abst-1975) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=1151651&dopt=abstractplus
The effect of cannabichromene on mean blood pressure, heart rate, and respiration rate responses to tetrahydrocannabinol in the anesthetized rat (abst–1979) http://www.sciencedirect.com/science/article/pii/0041008X79902503
Anti-inflammatory properties of cannabichromene (abst 1980) http://www.sciencedirect.com/science/article/pii/0024320580906311
Biological activity of cannabichromene, its homologs and isomers (abst-1981) http://www.ncbi.nlm.nih.gov/pubmed/7298870?dopt=Abstract
Patent 4315862 – Process for preparing cannabichromene (full-1982) http://www.freepatentsonline.com/4315862.html
Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol (abst–1983) http://www.ncbi.nlm.nih.gov/pubmed/6301931
Allergenic properties of naturally occurring cannabinoids (abst-1983) http://www.ncbi.nlm.nih.gov/pubmed/6620158
Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol (abst-1983) http://www.ncbi.nlm.nih.gov/pubmed/6301931
Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9-tetrahydrocannabinol or cannabichromene (abst–1984) http://www.ncbi.nlm.nih.gov/pubmed/6323206
Antiinflammatory and antimicrobial compounds and compositions United States Patent 4837228 (full-1989) http://www.freepatentsonline.com/4837228.html
In vitro metabolism of cannabichromene in seven common laboratory animals (abst–1990) http://www.ncbi.nlm.nih.gov/pubmed/1981514


CBD / CANNABIDIOL
Phytocannabinoids (news–undated) http://www.news-medical.net/health/Phytocannabinoids.aspx
ACCESSING 0.5 to 2.0 GRAMS CBD FRACTIONATING THE PHYTOCANNABINOIDS BY THEIR VAPORIZATION POINTS (article–forum repost-undated) http://forum.grasscity.com/medical-marijuana/610429-need-cbd.html
STUDIES ON THE PHARMACOLOGY AND ACUTE TOXICITY OF COMPOUNDS WITH MARIHUANA ACTIVITY (abst-1946) http://jpet.aspetjournals.org/content/88/2/154.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=marihuana&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
top
Chemical and Physiological Identification of Indian Hemp (test for CBD) (full–1950) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1950-01-01_3_page005.html
Some actions of delta-1 tetrahydrocannabinol and cannabidiol at cholinergic junctions (full–1971) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1703324/pdf/brjpharm00552-0217.pdf
A metabolic interaction in vivo between cannabidiol and Δ1-tetrahydrocannabinol (full-1972) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1666148/?tool=pubmed
Cardiovascular and respiratory effects of cannabis in cat and rat (full–1973) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1776461/
Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man (abst–1974) http://www.sciencedirect.com/science/article/pii/0014299974901290
Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol (abst–1975) http://www.ncbi.nlm.nih.gov/pubmed/1097148
Differential effect of cannabinol and cannabidiol on THC-induced responses during
abstinence in morphine-dependent rats (abst-1975) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=1237925&dopt=abstractplus
Constituents of Cannabis sativa L. VIII: Possible biological application of a new method to separate cannabidiol and cannabichromene (abst-1975) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=1151651&dopt=abstractplus
The influence of delta9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue
oxygen consumption (abst–1975) http://www.ncbi.nlm.nih.gov/pubmed/1197914
Absence of interaction between delta9-tetrahydrocannabinol (delta-THC) and cannabidiol (CBD) in aggression, muscle control and body temperature experiments in mice (abst–1975) http://www.ncbi.nlm.nih.gov/pubmed/1171491
Anticonvulsant activity of four oxygenated cannabidiol derivatives (abst–1975) http://www.ncbi.nlm.nih.gov/pubmed/1188178
Antibacterial activity of delta9-tetrahydrocannabinol and cannabidiol (abst-1976) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=1085130&dopt=abstractplus
Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats (abst-1977) http://jpet.aspetjournals.org/content/201/1/26.abstract?ijkey=8457ace5313942358e64d156c12d04bd3c7d5f21&keytype2=tf_ipsecsha
Comparative diuretic activity of delta9-tetrahydrocannabinol, cannabidiol, cannabinol and hydrochlorothiazide in the rat (abst–1977) http://www.ncbi.nlm.nih.gov/pubmed/849066?dopt=Abstract
In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas (abst-1977) http://www.ncbi.nlm.nih.gov/pubmed/616322
Interaction of cannabidiol and alcohol in humans (abst–1979) http://www.ncbi.nlm.nih.gov/pubmed/120541
CHRONIC ADMINISTRATION OF CANNABIDIOL TO HEALTHY VOLUNTEERS AND EPILEPTIC PATIENTS (full-1980) http://web.acsalaska.net/~warmgun/es201.html
Sedative activity of cannabis in relation to its delta’-trans-tetrahydrocannabinol and cannabidiol content (full-1981) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2071638/?tool=pmcentrez
Antiepileptic potential of cannabidiol analogs (abst-1981) http://www.ncbi.nlm.nih.gov/pubmed/7298873
The cannabinoids as potential antiepileptics (abst-1981) http://www.ncbi.nlm.nih.gov/pubmed/6975285
Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice (abst-1982) http://www.ncbi.nlm.nih.gov/pubmed/6129147
top
Anticonvulsant effects of the (-) and (+)isomers of cannabidiol and their dimethylheptyl homologs (abst-1982) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=7071126&dopt=abstractplus
Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects (abst–1982) http://www.ncbi.nlm.nih.gov/pubmed/6285406
Allergenic properties of naturally occurring cannabinoids (abst-1983) http://www.ncbi.nlm.nih.gov/pubmed/6620158
Ocular Hypotension, Ocular Toxicity, and Neurotoxicity in Response to Marihuana Extract and Cannabidiol (abst-1984)
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=6098513&dopt=abstractplus
Stimulation of Sphingomyelin Hydrolysis by Cannabidiol in Fibroblasts from a Niemannpick Patient (abst-1984) http://www.ncbi.nlm.nih.gov/pubmed/6732800
Treatment of Meige’s syndrome with cannabidiol (abst-1984) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=114
The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol (abst-1985) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=2994117&dopt=abstractplus
Beneficial and adverse effects of cannabidiol in a Parkinson patient with sinemet-induced dystonic dyskinesia (abst-1985) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=142
Open label evaluation of cannabidiol in dystonic movement disorders (full-1986) http://web.acsalaska.net/~warmgun/es017.html
EFFECTS OF CANNABIDIOL IN HUNTINGTON’S DISEASE (abst-1986) http://www.druglibrary.org/schaffer/hemp/medical/hunting1.htm
Cannabidiol in dystonic movement disorders (abst-1986) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=139
Patent 4758597 Cannabidiol and derivatives (full–1988) http://www.google.com.ar/patents/US4758597
The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation (abst-1989) http://www.ncbi.nlm.nih.gov/pubmed/2575149
Antianxiety effect of cannabidiol in the elevated plus-maze (abst–1990) http://www.ncbi.nlm.nih.gov/pubmed/1969666
Mammary excretion of cannabidiol in rabbits after intravenous administration (abst-1994) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=7897602&dopt=abstractplus
Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants (full-1998) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=20965&tool=pmcentrez
Hemp and Marijuana:Myths & Realities (full–1998) http://www.naihc.org/hemp_information/content/hemp.mj.html
Marijuana chemical tapped to fight strokes ? (news-1998) http://www.thefreelibrary.com/Marijuana+chemical+tapped+to+fight+strokes.-a020973037
Cannabinoid Antioxidant Protects Brain Cells — Without the High (news–1998) http://hempworld.com/HempPharm/articles/medicalm05.html
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors (full–1999) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC24203/
top


CBDA / CANNABIDIOLIC ACID
Purification and characterization of cannabidiolic-acid synthase from Cannabis sativa L. Biochemical analysis of a novel enzyme that catalyzes the oxidocyclization of cannabigerolic acid to cannabidiolic acid (full–1996) http://www.jbc.org/content/271/29/17411.long


CBG / CANNABIGEROL
Phytocannabinoids (news–undated) http://www.news-medical.net/health/Phytocannabinoids.aspx
Allergenic properties of naturally occurring cannabinoids (abst-1983) http://www.ncbi.nlm.nih.gov/pubmed/6620158
Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol (abst–1984) http://www.ncbi.nlm.nih.gov/pubmed/6499952
Identification of a New Chemotype in Cannabis sativa: Cannabigerol – Dominant Plants, Biogenetic and Agronomic Prospects (abst–1987) https://www.thieme-connect.com/DOI/DOI?10.1055/s-2006-962705
The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation (abst-1989) http://www.ncbi.nlm.nih.gov/pubmed/2575149
A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol (abst-1990) http://www.ncbi.nlm.nih.gov/pubmed/1965836
In vitro metabolism of cannabigerol in several mammalian species (abst–1990) http://www.ncbi.nlm.nih.gov/pubmed/2224182
Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells (abst-1998) http://www.ncbi.nlm.nih.gov/pubmed/9875457


CBR – CB1 CANNABINOID RECEPTOR
Cannabinoid Receptor Ligands (full-undated) http://www.tocris.com/pdfs/cannabinoid_receptor_review/page_001.html
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor (abst–1992) http://www.ncbi.nlm.nih.gov/pubmed/1470919
Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide (abst–1995) http://www.ncbi.nlm.nih.gov/pubmed/7589169
The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat (abst–1995) http://www.ncbi.nlm.nih.gov/pubmed/7488739
Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder (full–1996) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1909890/
Marijuana and chocolate (abst–1996) http://cacao-chocolate.com/choc-cannabis.html
Molecular Aspects of Cannabinoid Receptors (abst–1997) http://dl.begellhouse.com/journals/7b004699754c9fe6,0af6f0a055729f1f,27123f036bd79f8c.html
Cannabinoid-Induced Hypotension and Bradycardia in Rats Is Mediated by CB1-Like Cannabinoid Receptors (full-1997) http://jpet.aspetjournals.org/content/281/3/1030.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT
top
Pharmacology of cannabinoid CB1 and CB2 receptors (abst-1997) http://www.ncbi.nlm.nih.gov/pubmed/9336020?dopt=Abstract
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock (abst–1997) http://www.ncbi.nlm.nih.gov/pubmed/9394002
Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia (full–1998) http://www.jneurosci.org/content/18/1/451.long
Assessment of Anandamide Interaction with the Cannabinoid Brain Receptor: SR 141716A Antagonism Studies in Mice and Autoradiographic Analysis of Receptor Binding in Rat Brain (full–1998) http://jpet.aspetjournals.org/content/284/3/1209.long
Cardiovascular actions of cannabinoids and their generation during shock (abst–1998) http://www.ncbi.nlm.nih.gov/pubmed/9846953
Cannabinoid modulation of intestinal propulsion in mice (abst–1998) http://www.frontiersin.org/publications/9570450
Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor (full–1999) http://www.jbc.org/content/274/5/2794.long
Increased Mortality, Hypoactivity, and Hypoalgesia in Cannabinoid Cb1 Receptor Knockout Mice (full–1999) http://www.pnas.org/content/96/10/5780.long
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors (full–1999) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC24203/
Localization of Cannabinoid CB1 Receptors in the Human Anterior Eye and Retina (full–1999) http://iovs.arvojournals.org/article.aspx?articleid=2162341&resultClick=1
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors (abst–1999) http://link.springer.com/article/10.1007%2Fs002130050953
Cannabis and cannabinoids: pharmacology and rationale for clinical use (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10575283
Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain (abst-1999) http://www.ncbi.nlm.nih.gov/pubmed/10594647?dopt=Abstract
Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10080239


CBR – CB2 CANNABINOID RECEPTOR
Cannabinoid Receptor Ligands (full-undated) http://www.tocris.com/pdfs/cannabinoid_receptor_review/page_001.html
Cannabinoids enhance human B-cell growth at low nanomolar concentrations (full–1995) http://ac.els-cdn.com/001457939500746V/1-s2.0-001457939500746V-main.pdf?_tid=84cf5e30-1b93-11e5-b97a-00000aacb362&acdnat=1435275790_97d5fbd61b42513c58283075bc4c0918
Molecular Aspects of Cannabinoid Receptors (abst–1997) http://dl.begellhouse.com/journals/7b004699754c9fe6,0af6f0a055729f1f,27123f036bd79f8c.html
Pharmacology of cannabinoid CB1 and CB2 receptors (abst–1997) http://www.ncbi.nlm.nih.gov/pubmed/9336020?dopt=Abstract
Cannabis and cannabinoids: pharmacology and rationale for clinical use (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10575283


CBR – CBe
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors (full-1999) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC24203/
top


CBR – GPR55 / CB3 CANNABINOID RECEPTOR
Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain (abst-1999) http://www.ncbi.nlm.nih.gov/pubmed/9931487


CEREBRAL PALSY
Treatment of human spasticity with delta 9-tetrahydrocannabinol (abst–1981) http://www.ncbi.nlm.nih.gov/pubmed/6271839


CHEMICAL COMPOSITION
Compounds found in Cannabis Sativa (list-undated) http://www.ukcia.org/research/cannabis-compounds.htm
The physiological activity of cannabis sativa. Comparison of extracts from indian and American-grown drug upon human subjects (1st page–1913) http://onlinelibrary.wiley.com/doi/10.1002/jps.3080020104/abstract
The active principles of Cannabis indica resin. I (full-1938) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1264344/pdf/biochemj01029-0136.pdf
The Active Principles of Cannabis and the Pharmacology of the Cannabinols (full-1940) http://www.ukcia.org/research/TherapeuticPotentialMedicalUses.php
Chemical and Physiological Identification of Indian Hemp (test for CBD) (full–1950) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1950-01-01_3_page005.html
THE SPECTROPHOTOMETRIC DETECTION OF CANNABIS SATIVA RESIN (1st page–1953) http://onlinelibrary.wiley.com/doi/10.1111/j.2042-7158.1953.tb13950.x/abstract
HEMP AS A MEDICAMENT : Properties of isolated substances (full-1955) http://www.bushka.cz/KabelikEN/proprieties.html
HEMP AS A MEDICAMENT : Survey of clinical experiences (full-1955) http://www.bushka.cz/KabelikEN/survey.html
A comparative study on some chemical and biological characteristics of various samples of cannabis resin (full–1962) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1962-01-01_3_page005.html
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish (1st page-1964) http://pubs.acs.org/doi/abs/10.1021/ja01062a046
Recent Developments in Cannabis Chemistry (full-1972) http://www.onlinepot.org/medical/Dr_Tods_PDFs/s5_6.pdf
A SIMPLE METHOD FOR DEMONSTRATING TETRAHYDROCANNABINOLS IN FRESH OR FIXED FROZEN SECTIONS (full–1972) http://jhc.sagepub.com/content/20/10/827.full.pdf+html
Water-soluble derivatives of 1 -tetrahydrocannabinol (abst-1972) http://www.ncbi.nlm.nih.gov/pubmed/5043146
The chemistry and biological activity of cannabis (news-1972) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1972-01-01_2_page005.html
Cannabinoid Phenotypes in Cannabis sativa (abst-1973) http://www.nature.com/nature/journal/v245/n5421/abs/245147a0.html
Cannabinoid Profile and Elemental Uptake of Cannabis sativa L. as Influenced by Soil Characteristics (full-1975) http://www.votehemp.com/PDF/Cannabinoid_Profile_and_Elemental_Uptake_of_Cannabis_sativa_L._as_Influenced_by_Soil_Characteristics-1975.pdf
top
Constituents of Cannabis sativa L. II: Absence of cannabidiol in an african variant (abst–1975) http://onlinelibrary.wiley.com/doi/10.1002/jps.2600620214/abstract
Constituents of Cannabis sativa L. VIII: Possible biological application of a new method to separate cannabidiol and cannabichromene (abst-1975) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=1151651&dopt=abstractplus
Pharmacological activity of three fractions obtained by smoking cannabis through a water pipe (abst–1976) http://www.ncbi.nlm.nih.gov/pubmed/1048934
Cannabinoid patterns in seedlings of Cannabis sativa L. and their use in the determination of chemical race (abst–1977) http://www.ncbi.nlm.nih.gov/pubmed/19599
Chemical composition of Brazilian marihuana samples and the importance of several constituents to the pharmacological activity of the plant (abst–1977) http://www.ncbi.nlm.nih.gov/pubmed/609775
Cannabinoid formation in Cannabis sativa grafted inter-racially, and with two Humulus species (abst-1975) http://www.sciencedirect.com/science/article/pii/0031942275851004
The decomposition of acidic and neutral cannabinoids in organic solvents (abst–1977) http://www.ncbi.nlm.nih.gov/pubmed/17692
CHEMOTAXONOMY OF CANNABIS 1. CROSSBREEDING BETWEEN CANNABIS SATIVA AND C. RUDERALIS, WITH ANALYSIS OF CANNABINOID CONTENT (full-1978) http://www.cannabase.com/cl/bcga/journals/Beutler1979/Beutler1979.html
Cannabinoid composition and gland distribution in clone of Cannabis sativa L (Cannabaceae) (full–1978) https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1978-01-01_1_page007.html
Influence of photoperiodism on cannabinoid content of Cannabis sativa L (abst–1978) http://www.ncbi.nlm.nih.gov/pubmed/248289
An investigation of procedures reported to increase potency of marijuana: a chemical analysis and psychological interpretation (abst–1978) http://www.ncbi.nlm.nih.gov/pubmed/721338
Interrelationships of glandular trichomes and cannabinoid content. I: Developing pistillate bracts of Cannabis sativa L. (Cannabaceae) (full–1981) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1981-01-01_3_page007.html
Interrelationships of glandular trichomes and cannabinoid content II. Developing vegetative leaves of Cannabis sativa L. (Cannabaceae) (full-1981) http://www.cannabase.com/cl/bcga/journals/Turner1981b/turner1981b.html
Chemataxonomic researches in higher plants. XV Carotenoid and chlorophyll pigments in the leaves of Cannabis sativa L. (link to PDF-1981) http://www.notulaebotanicae.ro/index.php/nbha/article/view/144
Constituents of Cannabis sativa L., XX: the cannabinoid content of Mexican variants grown in Mexico and in Mississippi, United States of America (full-1982) http://www.cannabase.com/cl/bcga/journals/Turner1982a/turner1982a.html
Constituents of Cannabis sativa, XXV. Isolation of two new dihydrostilbenes from a Panamanian variant (abst–1984) http://www.ncbi.nlm.nih.gov/pubmed/6481358
Cannabinoid content of cannabis grown on the Danish island of Bornholm (abst–1985) http://www.ncbi.nlm.nih.gov/pubmed/3011164
Identification of a New Chemotype in Cannabis sativa: Cannabigerol – Dominant Plants, Biogenetic and Agronomic Prospects (abst–1987) https://www.thieme-connect.com/DOI/DOI?10.1055/s-2006-962705
UV-B radiation effects on photosynthesis, growth and cannabinoid production of two Cannabis sativa chemotypes (abst–1987) http://onlinelibrary.wiley.com/doi/10.1111/j.1751-1097.1987.tb04757.x/abstract;jsessionid=E27DFF97974EDECC7DCDFFD1EED18D17.d03t03
top
Oral vs. Inhaled Cannabinoids for Nausea/Vomiting from Cancer Chemotherapy (full-1988) http://www.druglibrary.org/schaffer/hemp/medical/pierson.html
Histochemical detection of hemp trichomes and their correlation with the THC content (abst-1988) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=2855383&dopt=abstractplus
Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency (abst-1990) http://jpet.aspetjournals.org/content/255/2/624.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=marihuana&searchid=1&FIRSTINDEX=240&resourcetype=HWCIT
Cannabinoid acids analysis (abst–1992) http://www.ncbi.nlm.nih.gov/pubmed/1503600
Some features of Cannabis plants grown in the United Kingdom from seeds of known origin (abst-1992) http://www.unboundmedicine.com/medline/ebm/record/1361557/abstract/
Chemical ecology of Cannabis (full – 1994) http://www.hempfood.com/IHA/iha01201.html
The Volatile Oil Composition of Fresh and Air-Dried Buds of Cannabis sativa (full–1996) http://www.medicinalgenomics.com/wp-content/uploads/2011/12/cannabis_volatiles.pdf
Effect of nitrogen on tetrahydrocannabinol (THC) content in hemp (Cannabis sativa L) leaves at different positions (full-1997) http://www.internationalhempassociation.org/jiha/jiha4207.html
Essential oil of Cannabis sativa L. strains (full–1997) http://www.internationalhempassociation.org/jiha/jiha4208.html
Immunochemical localization of tetrahydrocannabinol (THC) in cryofixed glandular trichomes of Cannabis (Cannabaceae) (full–1997) http://www.amjbot.org/content/84/3/336.full.pdf+html
Capillary electrochromatography of cannabinoids (abst–1998) http://www.ncbi.nlm.nih.gov/pubmed/11013726
Medical Cannabis Potency Testing Project (full-1999) http://www.maps.org/news-letters/v09n3/09320gie.html
Hemp Seed Oil : The Wonder Oil For the New Millennium (news-1999) http://www.ukcia.org/research/Happi/HempSeedOilTheWonderOilForTheNewMillennium.htm


CHEMOTHERAPY
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy (abst-1975) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=4
Delta-9-Tetrahydrocannibinol as an Antiemetic in Cancer Patients Receiving High-Dose Methotrexate (full-1979) http://www.ukcia.org/research/AntiemeticForMethotrexate.php
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo (abst-1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=5
Delta-9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy; a double-blind cross-over trial against placebo (abst-1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=27
Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol (abst-1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=107
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy (abst-1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=126
top
Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis (abst-1980) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=6
The antiemetic activity of tetrahydrocanabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy (abst-1980) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=24
Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine (abst-1980) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=3
Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis (abst-1980) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=131
Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications (abst-1981) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=88
Clinical experience with levonantradol hydrochloride in the prevention of cancer
chemotherapy-induced nausea and vomiting (abst–1981) http://www.ncbi.nlm.nih.gov/pubmed/7298877
Dose vs response of tetrahydroannabinol (THC) vs prochlorperazine as chemotherapy
antiemetics (abst-1981) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=30
Comparative trial of the antiemetic effects of THC and haloperidol (abst-1981) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=64
Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy (abst–1982) http://www.ncbi.nlm.nih.gov/pubmed/7139853
Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine (abst–1982) http://www.ncbi.nlm.nih.gov/pubmed/6284334
A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy (abst-1982) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=146
A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting (abst-1982) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=156
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy (full-1983) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011510/?tool=pmcentrez&page=1
Evaluation of the Use of Both Marijuana and THC in Cancer Patients for the Relief of Nausea and Vomiting Associated With Cancer Chemotherapy After Failure of Conventional Anti-Emetic Therapy: Efficacy and Toxicity (full–1983) http://www.gacareproject.com/wp-content/uploads/2014/02/Binder1.pdf
Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy (abst–1983) http://www.ncbi.nlm.nih.gov/pubmed/6309451
Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting (abst–1985) http://www.ncbi.nlm.nih.gov/pubmed/2981616
THC or Compazine for the cancer chemotherapy patient–the UCLA study. Part II: Patient drug preference (abst-1985) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=34
top
A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy (abst-1985) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=128
Nabilone: an alternative antiemetic for cancer chemotherapy (full-1986) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1777777
Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy (abst-1986) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=127
Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis (abst-1986) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=129
Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial (abst-1987) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=120
Efficacy of tetrahydrocannabinol in patients refractory to standard anti-emetic therapy (abst-1988) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=31
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues (abst–1988) http://www.ncbi.nlm.nih.gov/pubmed/2838294
Marijuana as antiemetic medicine : A Survey of Oncologists’ Experiences and Attitudes (full-1991) http://www.maps.org/docs/doblin-mt.html
Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy induced nausea and vomiting (abst-1991) http://www.ncbi.nlm.nih.gov/pubmed/1652611
An efficient new cannabinoid antiemetic in pediatric oncology (full-1995) http://www.druglibrary.org/olsen/hemp/iha/iha02210.html


CHILDREN / YOUNG ADULTS
HEMP AS A MEDICAMENT : Importance of hemp seeds in the tuberculosis therapy (forum thread-full-1955) (EDEZYME recipe) http://www.bushka.cz/KabelikEN/hempseed.html
Survey of adolescent drug use. I. Sex and grade distribution (full–1971) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1530048/pdf/amjph00747-0113.pdf
Adolescent Marihuana Use: Role of Parents and Peers (abst–1976) http://www.ncbi.nlm.nih.gov/pubmed/4726001
Nabilone: an alternative antiemetic for cancer chemotherapy (abst-1986) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=123
Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children (abst-1987) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=120
Marijuana Use in Pregnancy and Pregnancy Outcome (abst–1990) https://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-999442
Five-year follow-up of rural Jamaican children whose mothers used marijuana during pregnancy (abst–1991) http://www.ncbi.nlm.nih.gov/pubmed/1957518
Prenatal marijuana use and neonatal outcome (abst–1991) http://www.ncbi.nlm.nih.gov/pubmed/1886543
Analysis of Facial Shape in Children Gestationally Exposed to Marijuana, Alcohol, and/or Cocaine (abst-1992) http://pediatrics.aappublications.org/cgi/content/abstract/89/1/67?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=marihuana&searchid=1&FIRSTINDEX=960&resourcetype=HWCIT
top
60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment (abst–1992) http://www.ncbi.nlm.nih.gov/pubmed/1469105
Prenatal Marijuana Exposure and Neonatal Outcomes in Jamaica: An Ethnographic Study (full-1994) http://www.ukcia.org/research/can-babies.php
Prenatal exposure to marihuana and tobacco during infancy, early and middle childhood: effects and an attempt at synthesis (abst–1995) http://www.ncbi.nlm.nih.gov/pubmed/7786162
Prenatal tobacco and marijuana use among adolescents: effects on offspring gestational age, growth, and morphology (abst–1995) http://www.ncbi.nlm.nih.gov/pubmed/7724314
An efficient new cannabinoid antiemetic in pediatric oncology (abst-1995) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=7
The effectiveness of Drug Abuse Resistance Education (project DARE): 5-year follow-up results (abst–1996) http://www.ncbi.nlm.nih.gov/pubmed/8781009
Cannabis Cookies: a Cause of Coma (abst–1996) http://www.ncbi.nlm.nih.gov/pubmed/9156535
Mortality Within the First 2 Years in Infants Exposed to Cocaine, Opiate, or Cannabinoid During Gestation (abst-1997) http://pediatrics.aappublications.org/cgi/content/abstract/100/1/79?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=640&resourcetype=HWCIT
Maternal cannabis use and birth weight: a meta-analysis (abst–1997) http://www.ingentaconnect.com/content/carfax/cadd/1997/00000092/00000011/art00015
Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders (abst–1997) http://www.sciencedirect.com/science/article/pii/S0376871698000039
The Changing Pattern of Substance Abuse in Urban Adolescents (full–1998) http://archpedi.jamanetwork.com/article.aspx?articleid=189315&resultClick=3
Dr. Melanie Dreher, reefer researcher (interview-1998) http://www.cannabisculture.com/v2/articles/1404.html
Cannabis and pregnancy (full-1999) http://www.ukcia.org/research/CannabisAndPregnancy.php
Ganja mothers, ganja babies (news-1999) http://www.cannabisculture.com/articles/1422.html
Marijuana and ADD- Therapeutic uses of Medical Marijuana in the treatment of ADD (news-1999) http://www.onlinepot.org/medical/add&mmj.htm
Project DARE: no effects at 10-year follow-up (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10450631


CHOCOLATE
Marijuana and chocolate (abst–1996) http://cacao-chocolate.com/choc-cannabis.html
Chocolate: food or drug? (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10524390


CHOLERA
Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10218903
top


CHOLESTEROL
Cannabinoids impair the formation of cholesteryl ester in cultured human cells (full–1981) http://atvb.ahajournals.org/cgi/reprint/1/6/449


CHRONIC FATIGUE SYNDROME / MYALGIC ENCEPHALOMYELITIS
Myalgic Encephalomyelitis by Anonymous (anecdotal–undated) http://www.rxmarijuana.com/shared_comments/Myalgic_Encephalomyelitis.htm
A Practical treatise on nervous exhaustion(neurasthenia) aka Chronic Fatigue Syndrome (full–1894) https://archive.org/details/apracticaltreat03beargoog


COLITIS
Ulcerative Colitis and Marijuana (letter-1990) http://www.druglibrary.org/schaffer/hemp/medical/colitis1.htm


COPD / CHRONIC OBSTRUCTIVE PUMONARY DISEASE
Heavy Habitual Marijuana Smoking Does Not Cause an Accelerated Decline in FEV with Age (full-1997) http://www.420magazine.com/forums/copd-lung-function/151580-heavy-habitual-marijuana-smokingdoes-not-cause-accelerated-decline.html
Marijuana. Respiratory tract effects (abst-1997) http://www.ncbi.nlm.nih.gov/pubmed/9358987
Heavy Long-Term Marijuana Use Does Not Impair Lung Function (news-1997) http://www.erowid.org/plants/cannabis/cannabis_media7.shtml


CP 47,497
Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol (abst-1982) http://jpet.aspetjournals.org/content/223/2/516.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=Hexahydrocannabinol&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT


CP 50,556-1 / LEVONANTRADOL
Clinical experience with levonantradol hydrochloride in the prevention of cancer chemotherapy-induced nausea and vomiting (abst–1981) http://www.ncbi.nlm.nih.gov/pubmed/7298877
Randomised Clinical Trial of Levonantradol and Chlorpromazine in the Prevention of Radiotherapy-induced Vomiting (abst-1982) http://www.ncbi.nlm.nih.gov/pubmed/6754212
Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy (abst–1982) http://www.ncbi.nlm.nih.gov/pubmed/7139853
Respiratory and cardiovascular depressant effects of nabilone, N-methyllevonantradol
and delta 9-tetrahydrocannabinol in anesthetized cats (abst-1983) http://jpet.aspetjournals.org/content/227/2/508.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=marihuana&searchid=1&FIRSTINDEX=1920&resourcetype=HWCIT
top
Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy (abst–1983) http://www.ncbi.nlm.nih.gov/pubmed/6309451
Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting (abst–1985) http://www.ncbi.nlm.nih.gov/pubmed/2981616
Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10080239


CP 55,940
Molecular cloning of a human cannabinoid receptor which is also expressed in testis (full–1991) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1151556/
Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism (full-1992) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1907498/?tool=pmcentrez&page=1
Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide (full-1993) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175863/?tool=pmcentrez&page=1
Cannabinoids enhance human B-cell growth at low nanomolar concentrations (full–1995) http://ac.els-cdn.com/001457939500746V/1-s2.0-001457939500746V-main.pdf?_tid=84cf5e30-1b93-11e5-b97a-00000aacb362&acdnat=1435275790_97d5fbd61b42513c58283075bc4c0918
AM630, a competitive cannabinoid receptor antagonist (abst–1995) http://www.ncbi.nlm.nih.gov/pubmed/7776818
Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord (full-1997) http://jpet.aspetjournals.org/content/281/2/730.full
Cannabinoid Receptor Agonists Protect Cultured Rat Hippocampal Neurons from Excitotoxicity (full-1998) http://molpharm.aspetjournals.org/content/54/3/459.full
Potent Effects of a Selective Cannabinoid Receptor Agonist on Some Guinea Pig Medial Vestibular Nucleus Neurons (abst–1998) http://www.ncbi.nlm.nih.gov/pubmed/9650841
Cannabinoid modulation of intestinal propulsion in mice (abst–1998) http://www.frontiersin.org/publications/9570450
The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats (abst-1999) http://www.ncbi.nlm.nih.gov/pubmed/10611417


CROHN’S DISEASE
Marijuana and Crohn’s Disease (anecdotal-1997) http://www.rxmarihuana.com/chrohns3.htm


CYSTIC FIBROSIS
I have Cystic fibrosis (anecdotal-undated) http://www.masscann.org/consumption/73-medicine/314-i-have-cystic-fibrosis
Recreational use of psychoactive drugs by patients with cystic fibrosis (abst–1987) http://www.ncbi.nlm.nih.gov/pubmed/3497251
top